Abstract
The effects of donitriptan on systemic arterial-jugular venous oxygen saturation difference were evaluated in pentobarbitone-anesthetized pigs. Oxygen and carbon dioxide partial pressures in systemic arterial and jugular venous blood as well as hemoglobin oxygen saturation were determined by conventional blood gas analysis. Vehicle (40% polyethyleneglycol in saline, n = 9) or donitriptan (0.01, 0.04, 0.16, 0.63, 2.5, 10, and 40 μg/kg, n= 7) were cumulatively infused over 15 min/dose. The involvement of 5-hydroxytryptamine1B (5-HT1B) receptors was assessed in the presence of the 5-HT1B/1D receptor antagonist, GR 127935. Donitriptan decreased markedly and dose dependently jugular venous oxygen saturation [ED50 0.5 (0.3–1.1) μg/kg], in parallel with increases in carotid vascular resistance [ED50 0.9 (0.7–1.1) μg/kg]. Since arterial oxygen saturation and partial pressure remained unchanged, donitriptan significantly increased arteriovenous oxygen saturation difference from 0.63 μg/kg (maximal variation: 57 ± 18%, P< 0.05 compared with vehicle). Unexpectedly, donitriptan from 2.5 μg/kg induced marked and significant increases in carbon dioxide partial pressure (pVCO2) in venous blood (maximal increase 18.8 ± 5.7%; P < 0.05 compared with vehicle). Pretreatment with GR 127935 (0.63 mg/kg,n = 5) abolished the fall in venous oxygen saturation and the increase in carotid vascular resistance and reduced the increases in pVCO2 induced by donitriptan. The results demonstrate that donitriptan, via 5-HT1B receptor activation, decreases the oxygen saturation of venous blood draining the head, concomitantly with cranial vasoconstriction. Since donitriptan also increased pVCO2, an effect upon cerebral oxygen consumption and metabolism is suggested in addition to cranial vasoconstriction, which may be relevant to its headache-relieving effects.
Footnotes
-
DOI: 10.1124/jpet.102.047225
- Abbreviations:
- 5-HT
- 5-hydroxytryptamine
- AVA
- arteriovenous anastomosis
- AVOSD
- arterial-jugular venous oxygen saturation difference
- LVP
- left ventricular pressure
- TCBF
- total carotid blood flow
- ABF
- aortic blood flow
- LAD
- left anterior descending
- LADVR
- LAD vascular resistance
- AOS
- oxygen saturation in systemic arterial blood
- VOS
- venous oxygen saturation
- GR 127935
- N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2[-methyl-4(5-methyl-1,2,4)-oxadiazol-3-yl]-(1,1 biphenyl)-4-carboxamide dihydrochloride
- ANOVA
- analysis of variance
- HR
- heart rate
- Received November 21, 2002.
- Accepted January 22, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|